Summer Sale

50% off Premium Yearly

00days
00hrs
00mins
00secs

NYSE:PFE

Pfizer Inc (PFE)

26.17
+0.57 (2.23%)
as of Jun 11, 2026, 8:00:00 pm Market Open.
322 watching
0
TOP PICK
One of the world's best drug companies and as cheap as it's been in the long, long time.
TRADE
Large, US pharmaceutical stocks typically do well in a rising interest rate environment.
TOP PICK
BUY
A lot of international sales. Have one of the strongest pipelines. A great core holding.
PAST TOP PICK
(Top Pick March 29/04. Up 2.5%.) Lots of upside potential.
BUY
On his watch list. Have a very strong product offering. High quality management. Probably the best drug portfolio and retail pipeline.
DON'T BUY
The inclusion in the DOW is significant and we'll give it an upward bias. One of the best pharmaceutical companies in the world. There is competition and drug pipelines are a little tougher. A little expensive.
WEAK BUY
Is going to be listed in the Dow on Monday which will have a positive impact for the short term. As a multiple in the low 20's. Has decent growth, but it's less than the multiple. Probably reasonably valued and any upside would make it overvalued.
TOP PICK
Has reached about a 20-year valuation low. Relatively cheap.
TOP PICK
Have a great lineup of existing drug products and lots more in the pipeline. At about 18 X earnings. Cheap.
BUY
Thinks it's going to grow earnings at 15% this year.
PAST TOP PICK
(A top pick Dec 29/03. Up 7.2%.) Still likes. As far and away the best growth profile in pharmaceuticals. Growing the fastest even though it's the most expensive.
DON'T BUY
Have a very good pipeline. Faces significant generic exposure for the next few years because of patent exposure. On his focus list and will probably stay there for some time.
BUY
Feels it is going to move substantially higher in the next 12/18 months.
WAIT
Had a good run. Benefit you to wait. Buy when it is down a few dollars from current price.
Showing 646 to 660 of 801 entries